Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Income from Non-Controlling Interests (2020 - 2023)

Arcadia Biosciences (RKDA) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with -$5000.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Income from Non-Controlling Interests rose 75.0% year-over-year to -$5000.0, compared with a TTM value of -$5000.0 through Dec 2023, up 97.88%, and an annual FY2023 reading of -$5000.0, up 97.88% over the prior year.
  • Income from Non-Controlling Interests was -$5000.0 for Q2 2023 at Arcadia Biosciences, up from -$84000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$5000.0 in Q2 2023 and bottomed at -$774000.0 in Q3 2020.
  • Average Income from Non-Controlling Interests over 4 years is -$237384.6, with a median of -$161000.0 recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests plummeted 269.61% in 2021, then surged 98.49% in 2022.
  • Year by year, Income from Non-Controlling Interests stood at -$290000.0 in 2020, then increased by 5.17% to -$275000.0 in 2021, then skyrocketed by 69.45% to -$84000.0 in 2022, then surged by 94.05% to -$5000.0 in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for RKDA at -$5000.0 in Q2 2023, -$84000.0 in Q4 2022, and -$10000.0 in Q3 2022.